| Susanna E Carter, MD | |
|
800 Saint Vincents Dr Ste 500, Birmingham, AL 35205-1629 | |
| (205) 933-8334 | |
| (205) 933-8466 |
| Full Name | Susanna E Carter |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 800 Saint Vincents Dr Ste 500, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992906788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 31553 (Alabama) | Primary |
| 207V00000X | Obstetrics & Gynecology | 45478 (Tennessee) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Birmingham Obstetrics Gynecology, Pc | 9638068695 | 12 |
News Archive
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, according to data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute.
Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced it is expanding its flagship industry summit from a single annual gathering held each summer in its hometown of Salt Lake City to a semi-annual pair of conferences staged each spring and fall closer to both coasts.
Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).
› Verified 9 days ago
| Entity Name | Birmingham Obstetrics Gynecology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740390640 PECOS PAC ID: 9638068695 Enrollment ID: O20040315001268 |
News Archive
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, according to data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute.
Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced it is expanding its flagship industry summit from a single annual gathering held each summer in its hometown of Salt Lake City to a semi-annual pair of conferences staged each spring and fall closer to both coasts.
Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).
› Verified 9 days ago
| Entity Name | Together Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730840778 PECOS PAC ID: 0941693352 Enrollment ID: O20220301000747 |
News Archive
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, according to data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute.
Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced it is expanding its flagship industry summit from a single annual gathering held each summer in its hometown of Salt Lake City to a semi-annual pair of conferences staged each spring and fall closer to both coasts.
Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susanna E Carter, MD 800 Saint Vincents Dr Ste 500, Birmingham, AL 35205-1629 Ph: (205) 933-8334 | Susanna E Carter, MD 800 Saint Vincents Dr Ste 500, Birmingham, AL 35205-1629 Ph: (205) 933-8334 |
News Archive
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, according to data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute.
Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced it is expanding its flagship industry summit from a single annual gathering held each summer in its hometown of Salt Lake City to a semi-annual pair of conferences staged each spring and fall closer to both coasts.
Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).
› Verified 9 days ago
James R Dollar, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 48 Medical Park Dr E, Suite 355, Birmingham, AL 35235 Phone: 205-838-3036 Fax: 205-838-5832 | |
Richard Own Burney, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-996-3130 | |
Sarah Fort Whitehead, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 2006 Brookwood Med Ctr Dr Ste 700, Birmingham, AL 35209 Phone: 205-397-1286 Fax: 205-397-1340 | |
Kimberly Hoover, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Percy Charles Hudson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 806 Saint Vincents Dr, Suite 430, Birmingham, AL 35205 Phone: 205-939-2806 | |
Isuzu Meyer, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Sarah Dunk, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |